Azetidines as MEK inhibitors for the treatment of proliferative diseases

Azetidines as MEK inhibitors for the treatment of proliferative diseases

Abstract Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tsang, Tsze H, Bussenius, Joerg, Kennedy, Abigail R, Curtis, Jeffry Kimo, Blazey, Charles M, Koltun, Elena, Peto, Csaba J, Anand, Neel Kumar, Aay, Naing, Kim, Angie Inyoung, Joshi, Anagha Abhijit, Bowles, Owen Joseph, Costanzo, Simona, Dubenko, Larisa, Rice, Kenneth D, DeFina, Steven Charles, Manalo, Jean-Claire Limun
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.